| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697624 | Cancer Treatment Reviews | 2017 | 9 Pages |
Abstract
The simultaneous inhibition of BRAF and MEK appears the most effective treatment for melanomas harboring BRAF V600 mutation, although anti-PD1 antibodies appear to be less toxic. Further research is needed to increase the quality of evidence.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sandro Pasquali, Vanna Chiarion-Sileni, Carlo Riccardo Rossi, Simone Mocellin,